In cells with intact HR, DSBs that occur as a result of PARP1 inhibition can be resolved, but in tumour cells lacking HR, PARP1 inhibition leads to persistent DSBs and cell death [172,175]. The gene discussed is PARP1; the disease is neoplasm.